Clinical Trial: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Sponsor and Collaborators
New Mexico Cancer Care Alliance
Celgene Corporation
Contact
Contact: Valerie Parks, RN
505-925-0390
[email protected]
Principal Investigator
Clarie Verschraegen, MD University of New Mexico
ClinicalTrials.gov Identifier
NCT01202890
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.